Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2026 / Cilt: 24 Sayı: 2

A COMPARATIVE STUDY: HOW WERE CLINICAL RESEARCH ACTIVITIES AFFECTED IN THE FIRST YEAR OF THE PANDEMIC COMPARED TO THE PREVIOUS YEAR?

Recep Selim Şentürk(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DR. ABDURRAHMAN YURTASLAN ONKOLOJİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-6849-325X
Halil Kara(ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, TIBBİ FARMAKOLOJİ ANABİLİM DALI)0000-0002-7557-7897
Pages
303–308
Publication Date
2022-08-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: The main purpose of this study is to determine how clinical research activities in a Clinical Research Center in Ankara are affected by the Covid-19 pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The main purpose of this study is to determine how clinical research activities in a Clinical Research Center in Ankara are affected by the Covid-19 pandemic.
📊
Key Findings & Data:Objective: The main purpose of this study is to determine how clinical research activities in a Clinical Research Center in Ankara are affected by the Covid-19 pandemic.
💡
Conclusion & Impact:Objective: The main purpose of this study is to determine how clinical research activities in a Clinical Research Center in Ankara are affected by the Covid-19 pandemic.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:klinik araştırmalar · covid-19 pandemisi · onkoloji hastanesi

Abstract

Objective: The main purpose of this study is to determine how clinical research activities in a Clinical Research Center in Ankara are affected by the Covid-19 pandemic.

Özet

Amaç: Bu çalışmanın amacı, Ankara'da bulunan bir Klinik Araştırma Merkezi'ndeki klinik araştırma faaliyetlerinin Covid-19 pandemisinden nasıl etkilendiğini belirlemektir.

🔖

Cite This Article

Şentürk, R. S., Kara, H. (2022). A COMPARATIVE STUDY: HOW WERE CLINICAL RESEARCH ACTIVITIES AFFECTED IN THE FIRST YEAR OF THE PANDEMIC COMPARED TO THE PREVIOUS YEAR?. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 24 Sayı: 2, 303–308. https://doi.org/10.24938/kutfd.1074549

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. World Health Organisation (WHO). Listings of WHO’s response to COVID-19. Accessed date: 24 January 2022: https://www.who.int/news/item/29-06-2020-covidtimeline.
  2. T.C. Ministry of Health. COVID-19 (SARS-Cov-2 Infection) (Study of Scientific Board) General Information, Epidemiology and Diagnosis. Accessed date: 24 January 2022: https://hsgm.saglik.gov.tr/depo/covid19/Ingilizce/Rehber/COVID-19_Rehberi__Genel_bilgiler_epidemiyoloji_ve_tani_8.06.2020_eng.pdf.
  3. World Health Organisation (WHO). WHO Coronavirus (COVID-19) Dashboard. Accessed date: 24 January 2022: https://covid19.who.int.
  4. T.C. Ministry of Health. Pandemic Hospitals. Accessed date: 24 January 2022: https://dosyamerkez.saglik.gov.tr/Eklenti/36907, pandemi-hastaneleripdf.pdf?0.
  5. Grand View Research, Inc. Clinical Trials Market Size, Share & Growth Report, 2021-2028. Accessed date: 24 January 2022: https://www.grandviewresearch.com/industry-analysis/global-clinical-trials-market.
  6. Akan H. Current agenda in clinical trials. Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları (LLM) Dergisi. 2019;3(1):1-3.
  7. U.S Food and Drug Agency (FDA). Guidance on conduct of clinical trials of medical products during COVID-19 Public Health Emergency / Guidance for industry, investigators, and institutional review boards. Accessed date: 24 January 2022: https://www.fda.gov/media/136238/download.
  8. Upadhaya S, Yu JX, Oliva C, Hooton M, Hodge J, Hubbard-Lucey VM. Impact of COVID-19 on oncology clinical trials. Nat Rev Drug Discov. 2020;19(6):376-7.
  9. Medidata Solutions, Inc. Covid-19 and Clinical Trials: The Medidata Perspective Release 9.0. Accessed date: 24 January 2022: https://www.medidata.com/en/insight/covid-19-and-clinical-trials-the-medidata-perspective.